Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is Anticipated to Attain a Valuation of US$ 39.5 Bn Steady CAGR of 4.7% by the end of year 2028. Analysis by Future Market Insights, Inc. NEWARK, Del, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia (BPH) prostate treatment market is expected to reach a valuation of US$ 39.5 Bn in 2028, with demand growing at...